Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Takashi Kuroha"'
Autor:
Takako Saeki, Takashi Kuroha, Yuya Sato, Maasa Tamura, Akira Iguchi, Tomoyuki Ito, Hajime Yamazaki, Yumi Ito, Kazuhiro Yoshita, Naofumi Imai, Ichiei Narita, Hiroyuki Usuda
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-7 (2019)
Abstract Background Although most cases of tubulointerstitial nephritis in paraproteinemia are monoclonal light chain deposition-mediated, interstitial nephritis as neoplastic interstitial cell infiltration has rarely been described. On the other han
Externí odkaz:
https://doaj.org/article/7e939b55b135437e8a9a6d898d225d68
Autor:
Kyoko Fuse, Shun Uemura, Suguru Tamura, Tatsuya Suwabe, Takayuki Katagiri, Tomoyuki Tanaka, Takashi Ushiki, Yasuhiko Shibasaki, Naoko Sato, Toshio Yano, Takashi Kuroha, Shigeo Hashimoto, Tatsuo Furukawa, Miwako Narita, Hirohito Sone, Masayoshi Masuko
Publikováno v:
Cancer Medicine, Vol 8, Iss 11, Pp 5058-5067 (2019)
Abstract Although allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a curative therapy for high‐risk acute leukemia (AL), some patients still relapse. Since patients simultaneously have many prognostic factors, difficulties are as
Externí odkaz:
https://doaj.org/article/8d1233ea703143e2b9aef1ba17a3a18a
Autor:
Miwako Narita, Tatsuo Furukawa, Takashi Kuroha, Shigeo Hashimoto, Masayoshi Masuko, Tatsuya Suwabe, Hirohito Sone, Shun Uemura, Toshio Yano, Suguru Tamura, Takashi Ushiki, Kyoko Fuse, Takayuki Katagiri, Naoko Sato, Tomoyuki Tanaka, Yasuhiko Shibasaki
Publikováno v:
Cancer Medicine, Vol 8, Iss 11, Pp 5058-5067 (2019)
Cancer Medicine
Cancer Medicine
Although allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is a curative therapy for high‐risk acute leukemia (AL), some patients still relapse. Since patients simultaneously have many prognostic factors, difficulties are associated
Autor:
Masayoshi Masuko, Tatsuya Suwabe, Kyoko Fuse, Yasuhiko Shibasaki, Shigeo Hashimoto, Hirohito Sone, Miwako Narita, Toshio Yano, Tomoyuki Tanaka, Takayuki Katagiri, Takashi Ushiki, Naoko Sato, Takashi Kuroha, Tatsuo Furukawa
Publikováno v:
International Journal of Hematology. 108:282-289
The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) is a widely used tool for pre-transplant risk assessment. Allogeneic hematopoietic cell transplantation (HCT) is performed on patients with diverse backgrounds, highlighting t
Autor:
Hajime Yamazaki, Ichiei Narita, Hiroyuki Usuda, Akira Iguchi, Maasa Tamura, Yuya Sato, Naofumi Imai, Takako Saeki, Kazuhiro Yoshita, Tomoyuki Ito, Takashi Kuroha, Yumi Ito
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 20, Iss 1, Pp 1-7 (2019)
BMC Nephrology, Vol 20, Iss 1, Pp 1-7 (2019)
Background Although most cases of tubulointerstitial nephritis in paraproteinemia are monoclonal light chain deposition-mediated, interstitial nephritis as neoplastic interstitial cell infiltration has rarely been described. On the other hand, lympho
The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma
Publikováno v:
Internal Medicine
Five cases were treated by adding daily low-dose thalidomide (50 mg) to bortezomib and dexamethasone therapy for refractory multiple myeloma. This therapy was effective in four cases, with an improvement of bone pain and regression of M-protein. One
Autor:
Tomohiko Kamimura, Takanori Teshima, Mine Harada, Keitaro Matsuo, Takashi Kuroha, Koichi Akashi, Eijiro Omoto, Junichi Sugita, Shuichi Ota, Shuichi Taniguchi
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S57-S58
HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide (PTCy-haploPBSCT) ensures good graft-versus-host disease (GVHD) controls and low non-relapse mortality (NRM), however, it remains to be elucidated whether dose-reducti
Autor:
Hirohito Sone, Jun Takizawa, Masayoshi Masuko, Masato Moriyama, Kyoko Fuse, Toshio Yano, Yasuhiko Shibasaki, Tatsuo Furukawa, Miwako Narita, Takashi Kuroha, Hironori Kobayashi, Koyama S, Takashi Abe, Noriatsu Isahai, Yoshinobu Seki, Syukuko Miyakoshi, Takashi Ushiki, Tomoyuki Tanaka, Takashi Kozakai
Publikováno v:
Leukemia Research. 39:667-671
We focused on the level of reduction of Wilms' tumor gene 1 (WT1) mRNA in bone marrow as minimal residual disease during chemotherapies in adult acute myeloid leukemia (AML) patients. Forty-eight patients were enrolled in this study. Log levels of re
Autor:
K. Fuse, Takashi Kuroha, S. Uemura, N. Satou, T. Katagiri, Shigeo Hashimoto, T. Yano, T. Furukawa, S. Tamura, M. Masuko, T. Ushiki, Yasuhiko Shibasaki, T. Suwabe, M. Narita, Hirohito Sone, T. Tanaka
Publikováno v:
HemaSphere. 3:475
Autor:
Toshio Yano, Naoko Sato, Takayuki Katagiri, Takashi Ushiki, Tastuo Furukawa, Takashi Kuroha, Shigeo Hashimoto, Miwako Narita, Masayoshi Masuko, Tomoyuki Tanaka, Hirohito Sone, Shun Uemura, Kyoko Fuse, Tatsuya Suwabe, Yasuhiko Shibasaki
Publikováno v:
Blood. 132:5260-5260
[Background] Chromosome analysis is indispensable for the diagnosis and risk classification of acute myeloid leukemia (AML). A marker chromosome (MC) is a fragmented chromosome that cannot be identified as originating from an existing autosomal or se